Literature DB >> 34097090

[COVID-19 in neurology and psychiatry].

Peter Berlit1, Michael Bauer2.   

Abstract

Entities:  

Year:  2021        PMID： 34097090     DOI： 10.1007/s00115-021-01130-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  3 in total

1.  First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.

Authors:  Paul Baas; Arnaud Scherpereel; Anna K Nowak; Nobukazu Fujimoto; Solange Peters; Anne S Tsao; Aaron S Mansfield; Sanjay Popat; Thierry Jahan; Scott Antonia; Youssef Oulkhouir; Yolanda Bautista; Robin Cornelissen; Laurent Greillier; Francesco Grossi; Dariusz Kowalski; Jerónimo Rodríguez-Cid; Praveen Aanur; Abderrahim Oukessou; Christine Baudelet; Gérard Zalcman
Journal:  Lancet       Date:  2021-01-21       Impact factor: 79.321

2.  Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19.

Authors:  Jenny Meinhardt; Josefine Radke; Carsten Dittmayer; Jonas Franz; Carolina Thomas; Ronja Mothes; Michael Laue; Julia Schneider; Sebastian Brünink; Selina Greuel; Malte Lehmann; Olga Hassan; Tom Aschman; Elisa Schumann; Robert Lorenz Chua; Christian Conrad; Roland Eils; Werner Stenzel; Marc Windgassen; Larissa Rößler; Hans-Hilmar Goebel; Hans R Gelderblom; Hubert Martin; Andreas Nitsche; Walter J Schulz-Schaeffer; Samy Hakroush; Martin S Winkler; Björn Tampe; Franziska Scheibe; Péter Körtvélyessy; Dirk Reinhold; Britta Siegmund; Anja A Kühl; Sefer Elezkurtaj; David Horst; Lars Oesterhelweg; Michael Tsokos; Barbara Ingold-Heppner; Christine Stadelmann; Christian Drosten; Victor Max Corman; Helena Radbruch; Frank L Heppner
Journal:  Nat Neurosci       Date:  2020-11-30       Impact factor: 24.884

3.  Long COVID and chronic COVID syndromes.

Authors:  Stephen Halpin; Rory O'Connor; Manoj Sivan
Journal:  J Med Virol       Date:  2020-10-30       Impact factor: 20.693
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.